v3.26.1
Shareholders' Equity
12 Months Ended
Mar. 31, 2026
Text Block1 [Abstract]  
Shareholders' Equity
25
SHAREHOLDERS’ EQUITY
Common Stock
The changes in the number of issued shares of common stock and common stock held by the Company during the fiscal years ended March 31, 2026, 2025 and 2024 were as follows:
 

 
 
For the fiscal year ended March 31,
 
 
 
2026
 
 
2025
 
 
2024
(1)
 
 
 
Outstanding
 
 
In treasury
 
 
Outstanding
 
 
In treasury
 
 
Outstanding
 
 
In treasury
 
At beginning of period
    3,884,445,458       10,651,848       4,012,587,252       70,763,598       4,124,073,582       90,211,950  
Net change
    (56,947,318     (19,729     (128,141,794     (60,111,750     (111,486,330     (19,448,352
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
At end of period
    3,827,498,140       10,632,119       3,884,445,458       10,651,848       4,012,587,252       70,763,598  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
As resolved by the board of directors on May 15, 2024, the Company implemented a stock split of its common stock with an effective date of October 1, 2024, whereby each share of common stock owned by shareholders listed or recorded in the closing register of shareholders on the record date of September 30, 2024 was split into three shares. The number of common stock outstanding and in treasury are calculated based on the assumption that the stock split had been implemented at the beginning of the fiscal year ended March 31, 2024.
The total number of authorized shares of common stock was 9,000 
million at March 31, 2026 and 2025 with no stated value. All issued shares are fully paid. The details of the stock options and the restricted shares outstanding are described in Note 41 “Share-Based Payment.”
Stock split
As resolved by the board of directors on May 15, 2024, the Company implemented a stock split of its common stock (the “2024 Stock Split”) with an effective date of October 1, 2024, whereby each share of common stock owned by shareholders listed or recorded in the closing register of shareholders on the record date of September 30, 2024 was split into three shares. Since the total number of authorized shares and the total number of authorized shares of common stock needed to be increased in line with the ratio of the 2024 Stock Split, the Company amended its articles of incorporation with an effective date of October 1, 2024, as approved by shareholders at the 22nd ordinary general meeting of shareholders on June 27, 2024.
On May 13, 2026, the Company’s board of directors resolved to implement a stock split of its common stock (the “2026 Stock Split”). The resolution authorized that each share of common stock owned by shareholders listed or recorded in the closing register of shareholders on the record date of September 30, 2026, will be split into two shares. The effective date of the 2026 Stock Split is October 1, 2026. Due to the 2026 Stock Split, the Company’s board of directors also resolved to propose partial amendments to its articles
 
of incorporation at the 24th ordinary general meeting of shareholders scheduled for June 26, 2026. The proposed amendments are to increase the total number of authorized shares and the total number of authorized shares of common stock in line with the ratio of the 2026 Stock Split.
Repurchase and cancellation of own shares
For the resolutions and repurchases made before the 2024 Stock Split, the number of shares presented is on a
pre-stock-split
basis, while the number of shares after the 2024 Stock Split is presented on a post-stock-split basis in this section.
On November 14, 2023, the Company’s board of directors resolved to repurchase shares of its common stock and cancel all the repurchased shares. The resolution authorized the repurchase of up to the lesser of (i) an aggregate of 26,000,000 shares of its common stock and (ii) an aggregate of ¥150 billion between November 15, 2023 and March 31, 2024. On March 22, 2024, the Company completed the repurchase pursuant to the resolution, acquiring 20,132,000 shares of its common stock for ¥150 billion in aggregate. The Company cancelled all of the repurchased shares on April 15, 2024.
On May 15, 2024, the Company’s board of directors resolved to repurchase shares of its common stock and cancel all the repurchased shares. The resolution authorized the repurchase of up to the lesser of (i) an aggregate of 15,000,000 shares of its common stock and (ii) an aggregate of ¥100 billion between May 16, 2024 and July 31, 2024. On July 31, 2024, the Company completed the repurchase pursuant to the resolution, acquiring 9,561,800 shares of its common stock for ¥100 billion in aggregate. The Company cancelled all of the repurchased shares on August 20, 2024.
On November 14, 2024, the Company’s board of directors resolved to repurchase shares of its common stock and cancel all the repurchased shares. The resolution authorized the repurchase of up to the lesser of (i) an aggregate of 60,000,000 shares of its common stock and (ii) an aggregate of ¥150 billion between November 15, 2024 and January 31, 2025. On January 31, 2025, the Company completed the repurchase pursuant to the resolution, acquiring 40,086,100 shares of its common stock for ¥150 billion in aggregate. The Company cancelled all of the repurchased shares on February 20, 2025.
On May 14, 2025, the Company’s board of directors resolved to repurchase shares of its common stock and cancel all the repurchased shares. The resolution authorized the repurchase of up to the lesser of (i) an aggregate of 40,000,000 shares of its common stock and (ii) an aggregate of ¥100 billion between May 15, 2025 and July 31, 2025. On July 31, 2025, the Company completed the repurchase pursuant to the resolution, acquiring 27,551,100 shares of its common stock for ¥100 billion in aggregate. The Company cancelled all of the repurchased shares on August 20, 2025.
On November 14, 2025, the Company’s board of directors resolved to repurchase shares of its common stock and cancel all the repurchased shares. The resolution authorized the repurchase of up to the lesser of (i) an aggregate of 50,000,000 shares of its common stock and (ii) an aggregate of ¥150 
billion between November 17, 2025 and January 31, 2026. On January 31, 2026, the Company completed the repurchase pursuant to the resolution, acquiring 29,909,500 shares of its common stock for ¥150 billion in aggregate. The Company cancelled all of the repurchased shares on February 20, 2026.
On May 13, 2026, the Company’s board of directors resolved to repurchase shares of its common stock and cancel all the repurchased shares. The resolution authorized the repurchase of up to the lesser of (i) an aggregate of 40,000,000 shares of its common stock and (ii) an aggregate of ¥180 billion between May 14, 2026 and July 31, 2026. The cancellation of the repurchased shares is scheduled on August 20, 2026. During May 2026, the Company entered into contracts to repurchase 5,439,500 shares of its common stock for ¥32 billion in aggregate.
In addition, on March 27, 2024, the Company announced the introduction of a share-based compensation plan for employees of SMBC. The plan is an incentive scheme that establishes an Employee Stock Ownership
 
Plan (“ESOP”) trust which is funded by cash contributed by SMBC (via SMFG). The shares of the Company’s common stock acquired by the ESOP trust will be granted to SMBC employees upon their retirement based on the number of points earned by each employee. According to the rules of the share-based compensation plan for employees established by SMBC’s board of directors, the number of points granted to employees is linked to their grade and the business performance of SMFG. On May 15, 2024, the Company’s board of directors resolved the detail of the acquisition of its common stock up to an aggregate of 149,000 shares by the ESOP trust between May 23, 2024 and May 31, 2024.
On May 14, 2025, the Company announced that it added SMBC Nikko Securities Inc., Sumitomo Mitsui Card Company, Limited and The Japan Research Institute, Limited as subsidiaries eligible for the share-based compensation plan for employees, the introduction of which the Company announced on March 27, 2024. On the same day, the Company’s board of directors resolved the detail of the acquisition of its common stock up to an
 
aggregate of
153,000
shares by the ESOP trust between May 22, 2025 and May 30, 2025.
On December 22, 2025, the Company’s board of directors resolved to add SMBC Consumer Finance Co., Ltd. as a subsidiary eligible for the share-based compensation plan for employees, the introduction of which the Company announced on March 27, 2024. On May 13, 2026, the Company’s board of directors resolved the detail of the acquisition of its common stock up to an aggregate
 
of
1,094,000
shares by the ESOP trust between May 21, 2026 and May 29, 2026.
Preferred Stock
The following table shows the number of shares of preferred stock at March 31, 2026 and 2025.
 

 
  
At March 31, 2026
 
  
At March 31, 2025
 
 
  
Authorized
 
  
Issued
 
  
Authorized
 
  
Issued
 
Type 5 preferred stock
     167,000               167,000         
Type 7 preferred stock
     167,000               167,000         
Type 8 preferred stock
     115,000               115,000         
Type 9 preferred stock
     115,000               115,000         
All the preferred stocks have no stated value. There was no movement in preferred stock during the fiscal years ended March 31, 2026, 2025 and 2024.
Capital Stock, Capital Surplus and Treasury Stock
“Capital stock” represents share capital under the Companies Act of Japan (“Companies Act”) adjusted by the amount corresponding to the preferred stock which is accounted for as a liability under IFRS. Purchases of treasury stock are recognized at cost in “Treasury stock.” Any additional
paid-in
capital, net gains or losses on the sales of treasury stock, and other changes in equity resulting from transactions with shareholders except for dividends are included in “Capital surplus.”
Restriction on the Payment of Dividends
The amount of the capital surplus and retained earnings of the Company that can be paid out as dividends is subject to restrictions under the Companies Act. These amounts are calculated based on the Company’s nonconsolidated statement of financial position prepared in accordance with Japanese GAAP. Therefore, the adjustments made to prepare the IFRS consolidated financial statements have no impact on the calculation. The total amount that the Company can pay out as a dividend was ¥2,555 billion at March 31, 2026.
Other than the restriction by the Companies Act, the Company is required to maintain a risk-weighted capital ratio as per the Banking Act of Japan (“Banking Act”). The detail of the restriction is described in Note 47 “Financial Risk Management.” Therefore, the Company would not be able to pay a dividend if the ratio were to fall below the minimum amount as a result of the payment of the dividends.
 
Since the Company is a holding company, its earnings rely mostly on dividend income from SMBC, and the Company’s other subsidiaries and associates. SMBC is subject to some restrictions on its dividend payment by the Companies Act and the Banking Act, similar to those applied to the Company.
Other Reserves
Remeasurements of defined benefit plans reserve
Remeasurements of the defined benefit plans reserve includes the accumulated actuarial gains and losses arising from experience adjustments and changes in actuarial assumptions, and return on plan assets excluding interest income.
The movements of remeasurements of the defined benefit plans reserve for the fiscal years ended March 31, 2026, 2025 and 2024 were as follows:
 
    
For the fiscal year ended March 31,
 
    
2026
    
2025
   
2024
 
                     
    
(In millions)
 
At beginning of period
   ¥ 87,504      ¥  159,724     ¥  159,584  
Gains (losses) arising during the period, before tax
     96,497        (37,183     50,358  
Income tax (expense) benefit for changes arising during the period
     (30,563      8,168       (15,485
Amount attributable to
non-controlling
interests
     24        (102     44  
Share of other comprehensive income (loss) of associates and joint ventures
     339        (326     609  
Transfer from other reserves to retained earnings
     (58,805 )      (42,777     (35,386
  
 
 
    
 
 
   
 
 
 
At end of period
   ¥ 94,996      ¥ 87,504     ¥ 159,724  
  
 
 
    
 
 
   
 
 
 
Financial instruments at fair value through other comprehensive income reserve
The financial instruments at fair value through other comprehensive income (“FVOCI”) reserve includes the accumulated gains and losses of debt instruments measured at FVOCI and equity instruments measured at FVOCI under IFRS 9. The accumulated gains and losses related to debt instruments measured at FVOCI are reclassified to profit or loss when the assets are derecognized or impaired. The accumulated gains and losses related to equity instruments measured at FVOCI are transferred to retained earnings when the assets are derecognized. In addition, when the decline in the fair value of an equity instrument measured at FVOCI is above the threshold to qualify for a tax deduction, the accumulated losses related to the equity instrument are transferred to retained earnings.
 
The movements of the financial instruments at FVOCI reserve for the fiscal years ended March 31, 2026, 2025 and 2024 were as follows:
 
    
For the fiscal year ended March 31,
 
    
2026
    
2025
   
2024
 
                     
    
(In millions)
 
At beginning of period
   ¥ 2,160,119      ¥ 2,507,275     ¥ 1,575,193  
Gains (losses) arising during the period, before tax
     754,045        7,370       1,506,580  
Income tax (expense) benefit for changes arising during the period
     (238,104 )      (26,668     (454,951
Reclassification adjustments for (gains) losses included in net profit, before tax
     87,581        15,186       110,509  
Income tax (expense) benefit for reclassification adjustments
     (28,007 )      (5,693     (33,994
Amount attributable to
non-controlling
interests
     197        (37     (106
Share of other comprehensive income (loss) of associates and joint ventures
     4,000        1,951       8,578  
Transfer from other reserves to retained earnings
     (332,603 )      (339,265     (204,534
  
 
 
    
 
 
   
 
 
 
At end of period
   ¥ 2,407,228      ¥ 2,160,119     ¥ 2,507,275  
  
 
 
    
 
 
   
 
 
 
Own credit on financial liabilities designated at fair value through profit or loss reserve
The own credit on financial liabilities designated at fair value through profit or loss (“FVPL”) reserve includes the accumulated gains and losses arising from changes in fair value that is attributable to changes in own credit risk of financial liabilities designated at FVPL.
The movements of own credit on financial liabilities designated at fair value through profit or loss reserve for the fiscal years ended March 31, 2026, 2025 and 2024 were as follows:
 
    
For the fiscal year ended March 31,
 
    
2026
   
2025
   
2024
 
                    
    
(In millions)
 
At beginning of period
   ¥    7,675     ¥    1,177     ¥    9,433  
Gains (losses) arising during the period, before tax
     635       9,511       (11,900
Income tax (expense) benefit for changes arising during the period
     (200     (3,013     3,644  
  
 
 
   
 
 
   
 
 
 
At end of period
   ¥ 8,110     ¥ 7,675     ¥ 1,177  
  
 
 
   
 
 
   
 
 
 
Exchange differences on translating foreign operations reserve
Exchange differences on translating foreign operations reserve includes foreign exchange differences arising from the translation of the net assets of foreign operations from their functional currencies to the Group’s presentation currency, Japanese yen.
 
The movements of exchange differences on translating the foreign operations reserve for the fiscal years ended March 31, 2026, 2025 and 2024 were as follows:
 
    
For the fiscal year ended March 31,
 
    
2026
    
2025
   
2024
 
                     
    
(In millions)
 
At beginning of period
   ¥ 1,407,837      ¥ 1,402,658     ¥ 884,790  
Gains (losses) arising during the period, before tax
     361,685        (32,479     528,441  
Income tax (expense) benefit for changes arising during the period
     12,231        (216     (3,447
Reclassification adjustments for (gains) losses included in net profit, before tax
     39,944        (640     (11,258
Income tax (expense) benefit for reclassification adjustments
     (12,231      196       3,447  
Amount attributable to
non-controlling
interests
     (711 )      46       (3,324
Share of other comprehensive income (loss) of associates and joint ventures
     18,843        38,272       4,009  
  
 
 
    
 
 
   
 
 
 
At end of period
   ¥ 1,827,598      ¥
 
1,407,837     ¥
 
1,402,658